mRNA and microRNA expression profiles of radioresistant NCI‑H520 non‑small cell lung cancer cells

Guo,Wei; Xie,Li; Zhao,Long; Zhao,Yuehuan

doi:10.3892/mmr.2015.3600

mRNA and microRNA expression profiles of radioresistant NCI‑H520 non‑small cell lung cancer cells

Authors:
- Wei Guo
- Li Xie
- Long Zhao
- Yuehuan Zhao
View Affiliations

Affiliations: Ultrasound Diagnosis Department, Shandong Cancer Hospital and Institute, Jinan, Shandong 250117, P.R. China, Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong 250117, P.R. China
Published online on: April 8, 2015 https://doi.org/10.3892/mmr.2015.3600
Pages: 1857-1867
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To elucidate the mechanism of radioresistance in non‑small cell lung cancer (NSCLC) cells and to identify key molecules conferring radioresistance, the radioresistant subclone NCI‑H520/R, derived from the NCI‑H520 NSCLC cell line, was established with eight rounds of sublethal irradiation. The radioresistant features were subsequently assessed using a clonogenic assay, analysis of apoptosis and an MTT assay, the gene expression levels were examined using an Agilent Whole Human Genome 4x44 k Oligo microarray and Agilent Human miRCURY™ LNA array, and confirmed by reverse transcription‑quantitative polymerase chain reaction. Pathway analysis and Gene Ontology (GO) analysis were performed to determine the biological functions of the subset of differentially expressed genes. miRNA‑mRNA correlation analysis between the expression levels of each miRNA and all its predicted target genes was performed to further understand the radioresistance in the NCI‑H520 cells. Following eight rounds of sublethal irradiation, a total of 2,862 mRNAs were significantly differentially expressed in the NCI‑H520/R cells, including 893 upregulated genes and 1,969 downregulated genes. A total of 162 upregulated miRNAs and 274 downregulated miRNAs were significantly deregulated in the NCI‑H520/R cells. Multiple core regulatory processes and signaling pathways were identified as being of likely relevance to radioresistance in NCI‑H520/R cells, including the mitogen‑activated protein kinase signaling pathway and neurotrophin signaling pathway. The expression of genes associated with radioresistance reflects the complex biological processes involved in clinical cancer cell eradication and requires further investigation for future enhancement of therapy.

View Figures

View References

1	Evans M: Lung cancer: Needs assessment, treatment and therapies. Br J Nurs. 22:S15–S16. S18S20–12. 2013. View Article : Google Scholar : PubMed/NCBI
2	Koh PK, Faivre-Finn C, Blackhall FH and De Ruysscher D: Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy. Cancer Treat Rev. 38:626–640. 2012. View Article : Google Scholar
3	Thomas A, Rajan A, Lopez-Chavez A, Wang Y and Giaccone G: From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma. Ann Oncol. 24:577–585. 2013. View Article : Google Scholar :
4	Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
5	Asli NS, Pitulescu ME and Kessel M: MicroRNAs in organogenesis and disease. Curr Mol Med. 8:698–710. 2008. View Article : Google Scholar : PubMed/NCBI
6	Gangaraju VK and Lin H: MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol. 10:116–125. 2009. View Article : Google Scholar : PubMed/NCBI
7	Carthew RW and Sontheimer EJ: Origins and Mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009. View Article : Google Scholar : PubMed/NCBI
8	Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12. 2007. View Article : Google Scholar
9	Lowery AJ, Miller N, McNeill RE and Kerin MJ: MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res. 14:360–365. 2008. View Article : Google Scholar : PubMed/NCBI
10	Gaur A, Jewell DA, Liang Y, et al: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
11	Blower PE, Verducci JS, Lin S, et al: MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther. 6:1483–1491. 2007. View Article : Google Scholar : PubMed/NCBI
12	Xie L, Song X, Yu J, et al: Solute carrier protein family may involve in radiation-induced radioresistance of non-small cell lung cancer. J Cancer Res Clin Oncol. 137:1739–1747. 2011. View Article : Google Scholar : PubMed/NCBI
13	Altomare DA and Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464. 2005. View Article : Google Scholar : PubMed/NCBI
14	Sambade MJ, Camp JT, Kimple RJ, Sartor CI and Shields JM: Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. Radiother Oncol. 93:639–644. 2009. View Article : Google Scholar : PubMed/NCBI
15	Stuschke M, Sak A, Wurm R, et al: Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint. Int J Radiat Biol. 78:807–819. 2002. View Article : Google Scholar : PubMed/NCBI
16	Panganiban RA, Snow AL and Day RM: Mechanisms of radiation toxicity in transformed and non-transformed cells. Int J Mol Sci. 14:15931–15958. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
18	Ghosh S, Kumar A, Tripathi RP and Chandna S: Connexin-43 regulates p38-mediated cell migration and invasion induced selectively in tumour cells by low doses of γ-radiation in an ERK-1/2-independent manner. Carcinogenesis. 35:383–395. 2014. View Article : Google Scholar
19	Williams TM, Flecha AR, Keller P, et al: Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Mol Cancer Ther. 11:1193–1202. 2012. View Article : Google Scholar : PubMed/NCBI
20	Marampon F, Gravina GL, Di Rocco A, et al: MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals. Mol Cancer Ther. 10:159–168. 2011. View Article : Google Scholar : PubMed/NCBI
21	He Z, Jia C, Feng S, et al: TRPC5 channel is the mediator of neurotrophin-3 in regulating dendritic growth via CaMKIIα in rat hippocampal neurons. J Neurosci. 32:9383–9395. 2012. View Article : Google Scholar : PubMed/NCBI
22	Quadrato G and Di Giovanni S: Gatekeeper between quiescence and differentiation: p53 in axonal outgrowth and neurogenesis. Int Rev Neurobiol. 105:71–89. 2012.PubMed/NCBI
23	Skaper SD: The neurotrophin family of neurotrophic factors: an overview. Methods Mol Biol. 846:1–12. 2012.PubMed/NCBI
24	Murase S: Signal transducer and activator of transcription 3 (STAT3) degradation by proteasome controls a developmental switch in neurotrophin dependence. J Biol Chem. 288:20151–20161. 2013. View Article : Google Scholar : PubMed/NCBI
25	Patapoutian A and Reichardt LF: Trk receptors: Mediators of neurotrophin action. Curr Opin Neurobiol. 11:272–280. 2001. View Article : Google Scholar : PubMed/NCBI
26	Alsina FC, Ledda F and Paratcha G: New insights into the control of neurotrophic growth factor receptor signaling: implications for nervous system development and repair. J Neurochem. 123:652–661. 2012. View Article : Google Scholar : PubMed/NCBI